News
In medical diagnostics, CRISPR-based biosensors are promising in detecting disease biomarkers, pathogens, genetic mutations, etc. In the field of food safety, CRISPR-based sensors could be used to ...
Hosted on MSN27d
New CRISPR-based diagnostic test detects pathogens in blood without amplification - MSNIn CRISPR/Cas-based diagnostic tests, guide RNAs bind pathogen DNA or RNA, triggering Cas enzymes to become active and cleave the reporter nucleic acids that fluoresce when cleaved.
They also found that after the extra chromosome was removed, genes tied to nervous system development were more active and ...
Back in 1900 the life expectancy of people with Down Syndrome was 9 years. In 1984, it was 28 years, today it's leveled off ...
Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...
A novel, portable assay can deliver TB diagnoses in under an hour at low cost using samples of blood, saliva, or sputum, ...
For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...
Gene therapy has always held enormous promise to correct genetic diseases, but turning that potential into treatments has been challenging.
Scientific breakthroughs have had life-changing effects on our nation's health and economy. Now is not the time to slash ...
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on ...
Japanese researchers have successfully eliminated the extra chromosome responsible for Down syndrome using CRISPR gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results